Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 47.27 -0.11%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics ROE Ratio 2011-2024 | HALO

Annual ROE Ratio Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
336.0 119.04 204.47 85.46 -78.72 -32.28 30.22 317.18 -74.96 -165.35 417.59 -109.62 -181.37

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
417.59 -181.37 66.74

Quarterly ROE Ratio Halozyme Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
138.53 141.11 158.39 142.5 206.04 236.75 194.99 94.38 171.27 184.62 253.26 194.54 242.97 190.05 130.77 85.46 -0.46 -51.69 -84.72 -78.72 -42.09 -26.02 -19.28 -32.28 28.03 40.54 34.98 30.22 55.08 142.88 240.38 317.18 169.18 12.74 -132.5 -239.59 -188.66 -170.38 -147.23 -165.35 -42.61 102.94 256.91 417.6 298.6 161.14 17.82 -109.62 -269.53 -181.2 -123.91 -181.36 47.39 28.59 -88.4

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
417.6 -269.53 50.77